Literature DB >> 16670763

An immunologic homunculus for type 1 diabetes.

Dirk Homann1, George S Eisenbarth.   

Abstract

Autoimmune diseases such as the diabetes that develops in NOD mice depend on immunologic recognition of specific autoantigens, but recognition can result in a pathogenic or protective T cell response. A study by Du et al. in this issue of the JCI demonstrates that TGF-beta signaling by T cells recognizing the insulin peptide B:9-23 is essential for such protection and that this inhibitory cytokine functions in both a paracrine and an autocrine manner (see the related article beginning on page 1360). We propose that the insulin peptide B:9-23 and a conserved TCR motif form an "immunologic homunculus" underlying the relatively common targeting of insulin by T cells that, as demonstrated by the study of Du and coworkers, results in a protective T cell response, or diabetes, as shown by other investigators, for related T cell receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670763      PMCID: PMC1451212          DOI: 10.1172/JCI28506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  The cognitive paradigm and the immunological homunculus.

Authors:  I R Cohen
Journal:  Immunol Today       Date:  1992-12

2.  Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse.

Authors:  D Zekzer; F S Wong; L Wen; M Altieri; T Gurlo; H von Grafenstein; R S Sherwin
Journal:  Diabetes       Date:  1997-07       Impact factor: 9.461

3.  D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus.

Authors:  A M Valdes; G Thomson; J Graham; M Zarghami; B McNeney; I Kockum; A Smith; M Lathrop; A R Steenkiste; J S Dorman; J A Noble; J A Hansen; A Pugliese; A Lernmark
Journal:  Diabetologia       Date:  2005-11-18       Impact factor: 10.122

4.  How defects in central tolerance impinge on a deficiency in regulatory T cells.

Authors:  Zhibin Chen; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

6.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Authors:  Sally C Kent; Yahua Chen; Lisa Bregoli; Sue M Clemmings; Norma Sue Kenyon; Camillo Ricordi; Bernhard J Hering; David A Hafler
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

7.  Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Authors:  B O Roep; M A Atkinson; P M van Endert; P A Gottlieb; S B Wilson; J A Sachs
Journal:  J Autoimmun       Date:  1999-09       Impact factor: 7.094

8.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.

Authors:  Elmar Jaeckel; Myra A Lipes; Harald von Boehmer
Journal:  Nat Immunol       Date:  2004-09-19       Impact factor: 25.606

10.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

View more
  9 in total

1.  Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2015-08-10       Impact factor: 2.691

2.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

3.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

4.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

Review 5.  Insulin as an autoantigen in NOD/human diabetes.

Authors:  Li Zhang; Maki Nakayama; George S Eisenbarth
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

6.  Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Santiago Schnell; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2014-05-14       Impact factor: 2.691

7.  Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.

Authors:  Anmar Khadra; Massimo Pietropaolo; Gerald T Nepom; Arthur Sherman
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

8.  Primer: immunity and autoimmunity.

Authors:  Massimo Pietropaolo; Julie M Surhigh; Patrick W Nelson; George S Eisenbarth
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461

9.  A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 Diabetes in Humanized NOD Mice.

Authors:  Mengjun Zhang; Yuanqiang Wang; Xiangqian Li; Gang Meng; Xiaoling Chen; Lina Wang; Zhihua Lin; Li Wang
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.